- Dicerna Reports First Quarter 2018 Financial and Operating Results and Provides Corporate Update
- Dicerna to Report First Quarter 2018 Financial Results and Host Conference Call on May 14, 2018
- Dicerna Pharmaceuticals Announces Settlement of All Litigation with Alnylam
- Dicerna to Present at the H.C. Wainwright Global Life Sciences Conference
- Dicerna to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
- Dicerna Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update
- Dicerna to Present at the Cowen and Company 38th Annual Health Care Conference
- Dicerna to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on March 8, 2018
Dicerna Pharmaceuticals Inc (DRNA:NSQ) closed at 13.77, -12.85% below its 52-week high of 15.80, set on May 15, 2018.
2.69Aug 22 201715.80May 15 2018
Markit short selling activity
|Market cap||714.28m USD|
|EPS (TTM)||-3.28 |
Data delayed at least 15 minutes, as of May 25 2018 21:00 BST.